| GILD |
Gilead Sciences, Inc. |
0 |
5.36% |
|
|
|
|
|
N/A |
0.00% |
27.43% |
24.89% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
5.03% |
|
|
|
|
|
N/A |
0.00% |
35.20% |
14.84% |
|---|
| NTRA |
Natera, Inc. |
0 |
5.02% |
|
|
|
|
|
N/A |
0.00% |
38.87% |
11.38% |
|---|
| BIIB |
Biogen Inc. |
0 |
4.91% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
14.76% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
4.90% |
|
|
|
|
|
N/A |
0.00% |
32.96% |
18.93% |
|---|
| INCY |
Incyte Corporation |
0 |
4.85% |
|
|
|
|
|
N/A |
0.00% |
31.86% |
27.85% |
|---|
| ILMN |
Illumina, Inc. |
0 |
4.85% |
|
|
|
|
|
N/A |
0.00% |
44.68% |
21.03% |
|---|
| AMGN |
Amgen Inc. |
0 |
4.60% |
|
|
|
|
|
N/A |
0.00% |
23.53% |
11.27% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
3.08% |
|
|
|
|
|
N/A |
0.00% |
31.38% |
21.40% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
2.98% |
|
|
|
|
|
N/A |
0.00% |
49.98% |
29.40% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
2.98% |
|
|
|
|
|
N/A |
0.00% |
96.79% |
44.93% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
2.93% |
|
|
|
|
|
N/A |
0.00% |
44.07% |
21.90% |
|---|
| QGEN |
Qiagen N.V. |
0 |
2.92% |
|
|
|
|
|
N/A |
0.00% |
33.20% |
36.11% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
2.89% |
|
|
|
|
|
N/A |
0.00% |
40.24% |
36.95% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
58.62% |
41.02% |
|---|
| MNKD |
MannKind Corporation |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
648.79% |
30.62% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
50.88% |
58.68% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
2.83% |
|
|
|
|
|
N/A |
0.00% |
39.12% |
22.55% |
|---|
| TECH |
Bio-Techne Corporation |
0 |
2.76% |
|
|
|
|
|
N/A |
0.00% |
46.78% |
50.75% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
2.74% |
|
|
|
|
|
N/A |
0.00% |
215.40% |
42.07% |
|---|
| RPRX |
Royalty Pharma plc |
0 |
2.71% |
|
|
|
|
|
N/A |
0.00% |
25.92% |
39.54% |
|---|
| BPMC |
Blueprint Medicines Corp |
|
2.68% |
|
|
|
|
|
|
|
|
|
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
0 |
2.66% |
|
|
|
|
|
N/A |
0.00% |
159.78% |
52.94% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
2.64% |
|
|
|
|
|
N/A |
0.00% |
45.75% |
13.13% |
|---|
| XNCR |
Xencor, Inc. |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
N/A |
66.89% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
2.61% |
|
|
|
|
|
N/A |
0.00% |
21.45% |
20.67% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
0 |
2.50% |
|
|
|
|
|
N/A |
0.00% |
39.05% |
10.65% |
|---|
| CDNA |
CareDx, Inc |
0 |
2.46% |
|
|
|
|
|
N/A |
0.00% |
1,072.18% |
32.10% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
2.41% |
|
|
|
|
|
N/A |
0.00% |
63.66% |
34.75% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
115.89% |
39.59% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
|---|